Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Gas vesicles (GVs) are genetically encodable, air-filled protein nanostructures that have rapidly emerged as a versatile platform for biomedical imaging, cell tracking, and therapeutic delivery. However, their heterologous expression in non-native hosts such as can be challenging due to the complex assembly process, which often involves around ten different proteins and can lead to proteotoxic stress and impair cell growth. Here, we report the observation of a drop in cell density occurring 8 to 16 hours after GV induction in . To address these, we developed a dual-inducer transcriptional regulation system that enables orthogonal control of GV assembly factor proteins and the shell protein over a range of stoichiometries. Sequential induction in time, in which assembly factor expression is initiated before shell protein expression, restored normal bacterial growth and prevented lysis without compromising GV production. Further analysis revealed that varying the interval between the two induction steps affected both GV yields and cellular stress. By preserving cell integrity with GV expression, our approach enhances the utility of GV-expressing bacteria in applications that demand population-wide cellular stability and facilitates their broader application in biomedical engineering and synthetic biology.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12262503PMC
http://dx.doi.org/10.1101/2025.06.20.660610DOI Listing

Publication Analysis

Top Keywords

gas vesicles
8
assembly factor
8
shell protein
8
expression
5
temporal gene
4
gene regulation
4
regulation enables
4
enables controlled
4
controlled expression
4
expression gas
4

Similar Publications

Adenoid cystic carcinoma (ACC) is a lethal salivary gland malignant neoplasm. Lung metastasis is the primary cause of mortality in ACC patients while there is no effective treatment available at present. In this study, a precise and biomimetic nanoplatform, CG/MC/U-M, is designed to combine cuproptosis, gas therapy and immunotherapy against metastatic adenoid cystic carcinoma.

View Article and Find Full Text PDF

Background: Vitamin D decomposition products target a myristic acid sidechain of the predominant glycerophospholipid constructed in the biomembranes of causing gastric cancer in humans, and disrupt the membrane structure, followed by bacteriolysis. No earlier studies, however, elucidate whether vitamin D decomposition products interact with the glycerophospholipids that construct the eukaryotic biomembranes and confer whatever cell disorders.

Methods: A gastric cancer cell line, MKN45, and a non-cancer cell line, Vero, were used in this study.

View Article and Find Full Text PDF

CO₂ geological utilization and storage involve complex multiphase interfacial behaviors that significantly influence the overall efficiency. Recently, bio-based materials have attracted increasing attention as promising candidates for interfacial regulation owing to their structural diversity, abundance, and environmental compatibility. This review summarizes recent advances in utilizing biomass-derived materials to regulate interfacial behaviors in subsurface multiphase systems.

View Article and Find Full Text PDF

Inflammatory bowel diseases (IBD) affect millions of people globally, result in severe symptoms, and are difficult to diagnose and monitor - often necessitating the use of invasive and costly methods such as colonoscopies or endoscopies. Engineered gut bacteria offer a promising alternative due to their ability to persist in the gastrointestinal (GI) tract and sense and respond to specific environmental signals. However, probiotics that have previously been engineered to report on inflammatory and other disease biomarkers in the Gl tract rely on fluorescent or bioluminescent reporters, whose signals cannot be resolved in situ due to the poor penetration of light in tissue, or on colorimetric reporters which rely on plating feces.

View Article and Find Full Text PDF

Fetal therapies in congenital diaphragmatic hernia: a review of possibilities and practical challenges.

Semin Fetal Neonatal Med

August 2025

Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto, Canada; Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto, Canada; Division of Pediatric Surgery, Department of Surgery, St. Louis Chil

Congenital diaphragmatic hernia (CDH) is characterized by pulmonary hypoplasia. CDH lungs exhibit an inflammatory signature with impaired growth, maturation, and vascularization, which postnatally result in altered gas exchange and pulmonary hypertension. These pulmonary abnormalities are drivers of poor survival and long-term morbidity.

View Article and Find Full Text PDF